The American College of Medical Genetics and Genomics (ACMG) provides recommendations for reporting incidental findings in clinical exome and genome sequencing. The policy emphasizes the importance of alerting patients to the possibility of incidental findings and outlines a minimum list of conditions, genes, and variants that should be reported to clinicians. The recommendations are based on clinical consensus and are intended to be updated annually as more data becomes available. The document discusses the ethical considerations, the role of clinicians and laboratories, and the implications of reporting incidental findings, especially in children.
documents/EFTA01140256.pdf
{}